Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Expanding the spectrum of PEX16 mutations and novel insights into disease mechanisms.

Kumar KR, Wali G, Davis RL, Mallawaarachchi AC, Palmer EE, Gayevskiy V, Minoche AE, Veivers D, Dinger ME, Mackay-Sim A, Cowley MJ, Sue CM.

Mol Genet Metab Rep. 2018 Jul 20;16:46-51. doi: 10.1016/j.ymgmr.2018.07.003. eCollection 2018 Sep.

2.

Patient-Derived Stem Cell Models in SPAST HSP: Disease Modelling and Drug Discovery.

Wali G, Sue CM, Mackay-Sim A.

Brain Sci. 2018 Jul 31;8(8). pii: E142. doi: 10.3390/brainsci8080142. Review.

3.

FANTOM5 CAGE profiles of human and mouse samples.

Noguchi S, Arakawa T, Fukuda S, Furuno M, Hasegawa A, Hori F, Ishikawa-Kato S, Kaida K, Kaiho A, Kanamori-Katayama M, Kawashima T, Kojima M, Kubosaki A, Manabe RI, Murata M, Nagao-Sato S, Nakazato K, Ninomiya N, Nishiyori-Sueki H, Noma S, Saijyo E, Saka A, Sakai M, Simon C, Suzuki N, Tagami M, Watanabe S, Yoshida S, Arner P, Axton RA, Babina M, Baillie JK, Barnett TC, Beckhouse AG, Blumenthal A, Bodega B, Bonetti A, Briggs J, Brombacher F, Carlisle AJ, Clevers HC, Davis CA, Detmar M, Dohi T, Edge ASB, Edinger M, Ehrlund A, Ekwall K, Endoh M, Enomoto H, Eslami A, Fagiolini M, Fairbairn L, Farach-Carson MC, Faulkner GJ, Ferrai C, Fisher ME, Forrester LM, Fujita R, Furusawa JI, Geijtenbeek TB, Gingeras T, Goldowitz D, Guhl S, Guler R, Gustincich S, Ha TJ, Hamaguchi M, Hara M, Hasegawa Y, Herlyn M, Heutink P, Hitchens KJ, Hume DA, Ikawa T, Ishizu Y, Kai C, Kawamoto H, Kawamura YI, Kempfle JS, Kenna TJ, Kere J, Khachigian LM, Kitamura T, Klein S, Klinken SP, Knox AJ, Kojima S, Koseki H, Koyasu S, Lee W, Lennartsson A, Mackay-Sim A, Mejhert N, Mizuno Y, Morikawa H, Morimoto M, Moro K, Morris KJ, Motohashi H, Mummery CL, Nakachi Y, Nakahara F, Nakamura T, Nakamura Y, Nozaki T, Ogishima S, Ohkura N, Ohno H, Ohshima M, Okada-Hatakeyama M, Okazaki Y, Orlando V, Ovchinnikov DA, Passier R, Patrikakis M, Pombo A, Pradhan-Bhatt S, Qin XY, Rehli M, Rizzu P, Roy S, Sajantila A, Sakaguchi S, Sato H, Satoh H, Savvi S, Saxena A, Schmidl C, Schneider C, Schulze-Tanzil GG, Schwegmann A, Sheng G, Shin JW, Sugiyama D, Sugiyama T, Summers KM, Takahashi N, Takai J, Tanaka H, Tatsukawa H, Tomoiu A, Toyoda H, van de Wetering M, van den Berg LM, Verardo R, Vijayan D, Wells CA, Winteringham LN, Wolvetang E, Yamaguchi Y, Yamamoto M, Yanagi-Mizuochi C, Yoneda M, Yonekura Y, Zhang PG, Zucchelli S, Abugessaisa I, Arner E, Harshbarger J, Kondo A, Lassmann T, Lizio M, Sahin S, Sengstag T, Severin J, Shimoji H, Suzuki M, Suzuki H, Kawai J, Kondo N, Itoh M, Daub CO, Kasukawa T, Kawaji H, Carninci P, Forrest ARR, Hayashizaki Y.

Sci Data. 2017 Aug 29;4:170112. doi: 10.1038/sdata.2017.112.

4.

DNA methylation in schizophrenia in different patient-derived cell types.

Vitale AM, Matigian NA, Cristino AS, Nones K, Ravishankar S, Bellette B, Fan Y, Wood SA, Wolvetang E, Mackay-Sim A.

NPJ Schizophr. 2017 Jan 23;3:6. doi: 10.1038/s41537-016-0006-0. eCollection 2017.

5.

A Patient-Specific Stem Cell Model to Investigate the Neurological Phenotype Observed in Ataxia-Telangiectasia.

Stewart R, Wali G, Perry C, Lavin MF, Féron F, Mackay-Sim A, Sutharsan R.

Methods Mol Biol. 2017;1599:391-400. doi: 10.1007/978-1-4939-6955-5_28.

PMID:
28477134
6.

Cell migration in schizophrenia: Patient-derived cells do not regulate motility in response to extracellular matrix.

Tee JY, Sutharsan R, Fan Y, Mackay-Sim A.

Mol Cell Neurosci. 2017 Apr;80:111-122. doi: 10.1016/j.mcn.2017.03.005. Epub 2017 Mar 9.

7.

Schizophrenia patient-derived olfactory neurosphere-derived cells do not respond to extracellular reelin.

Tee JY, Sutharsan R, Fan Y, Mackay-Sim A.

NPJ Schizophr. 2016 Aug 17;2:16027. doi: 10.1038/npjschz.2016.27. eCollection 2016.

8.

Olfactory ensheathing cells but not fibroblasts reduce the duration of autonomic dysreflexia in spinal cord injured rats.

Cloutier F, Kalincik T, Lauschke J, Tuxworth G, Cavanagh B, Meedeniya A, Mackay-Sim A, Carrive P, Waite P.

Auton Neurosci. 2016 Dec;201:17-23. doi: 10.1016/j.autneu.2016.08.015. Epub 2016 Aug 24.

PMID:
27574816
9.

A Grand Challenge. 2. Phenotypic Profiling of a Natural Product Library on Parkinson's Patient-Derived Cells.

Vial ML, Zencak D, Grkovic T, Gorse AD, Mackay-Sim A, Mellick GD, Wood SA, Quinn RJ.

J Nat Prod. 2016 Aug 26;79(8):1982-9. doi: 10.1021/acs.jnatprod.6b00258. Epub 2016 Jul 22.

10.

Mechanism of impaired microtubule-dependent peroxisome trafficking and oxidative stress in SPAST-mutated cells from patients with Hereditary Spastic Paraplegia.

Wali G, Sutharsan R, Fan Y, Stewart R, Tello Velasquez J, Sue CM, Crane DI, Mackay-Sim A.

Sci Rep. 2016 May 27;6:27004. doi: 10.1038/srep27004.

11.

Rotenone Susceptibility Phenotype in Olfactory Derived Patient Cells as a Model of Idiopathic Parkinson's Disease.

Murtaza M, Shan J, Matigian N, Todorovic M, Cook AL, Ravishankar S, Dong LF, Neuzil J, Silburn P, Mackay-Sim A, Mellick GD, Wood SA.

PLoS One. 2016 Apr 28;11(4):e0154544. doi: 10.1371/journal.pone.0154544. eCollection 2016.

12.

Reduced protein synthesis in schizophrenia patient-derived olfactory cells.

English JA, Fan Y, Föcking M, Lopez LM, Hryniewiecka M, Wynne K, Dicker P, Matigian N, Cagney G, Mackay-Sim A, Cotter DR.

Transl Psychiatry. 2015 Oct 20;5:e663. doi: 10.1038/tp.2015.119.

13.

Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients.

Topol A, English JA, Flaherty E, Rajarajan P, Hartley BJ, Gupta S, Desland F, Zhu S, Goff T, Friedman L, Rapoport J, Felsenfeld D, Cagney G, Mackay-Sim A, Savas JN, Aronow B, Fang G, Zhang B, Cotter D, Brennand KJ.

Transl Psychiatry. 2015 Oct 20;5:e662. doi: 10.1038/tp.2015.118.

14.

Multipotent human stromal cells isolated from cord blood, term placenta and adult bone marrow show distinct differences in gene expression pattern.

Matigian N, Brooke G, Zaibak F, Rossetti T, Kollar K, Pelekanos R, Heazlewood C, Mackay-Sim A, Wells CA, Atkinson K.

Genom Data. 2014 Nov 28;3:70-4. doi: 10.1016/j.gdata.2014.11.011. eCollection 2015 Mar.

15.

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations.

Abrahamsen G, Fan Y, Matigian N, Wali G, Bellette B, Sutharsan R, Raju J, Wood SA, Veivers D, Sue CM, Mackay-Sim A.

Dis Model Mech. 2015 Oct 1;8(10):1339. doi: 10.1242/dmm.023002. No abstract available.

16.

Isolating dividing neural and brain tumour cells for gene expression profiling.

Endaya B, Cavanagh B, Alowaidi F, Walker T, de Pennington N, Ng JM, Lam PY, Mackay-Sim A, Neuzil J, Meedeniya AC.

J Neurosci Methods. 2016 Jan 15;257:121-33. doi: 10.1016/j.jneumeth.2015.09.020. Epub 2015 Oct 9.

PMID:
26432933
17.

Labeling of Cellular DNA with a Cyclosal Phosphotriester Pronucleotide Analog of 5-ethynyl-2'-deoxyuridine.

Huynh N, Dickson C, Zencak D, Hilko DH, Mackay-Sim A, Poulsen SA.

Chem Biol Drug Des. 2015 Oct;86(4):400-9. doi: 10.1111/cbdd.12506. Epub 2015 Jan 31.

PMID:
25557046
18.

Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Dando SJ, Mackay-Sim A, Norton R, Currie BJ, St John JA, Ekberg JA, Batzloff M, Ulett GC, Beacham IR.

Clin Microbiol Rev. 2014 Oct;27(4):691-726. doi: 10.1128/CMR.00118-13. Review.

19.

Low dose tubulin-binding drugs rescue peroxisome trafficking deficit in patient-derived stem cells in Hereditary Spastic Paraplegia.

Fan Y, Wali G, Sutharsan R, Bellette B, Crane DI, Sue CM, Mackay-Sim A.

Biol Open. 2014 May 23;3(6):494-502. doi: 10.1242/bio.20147641.

20.

An acute growth factor treatment that preserves function after spinal cord contusion injury.

Chehrehasa F, Cobcroft M, Young YW, Mackay-Sim A, Goss B.

J Neurotrauma. 2014 Nov 1;31(21):1807-13. doi: 10.1089/neu.2013.3294. Epub 2014 Sep 4.

PMID:
24836764
21.

Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis.

St John JA, Ekberg JA, Dando SJ, Meedeniya AC, Horton RE, Batzloff M, Owen SJ, Holt S, Peak IR, Ulett GC, Mackay-Sim A, Beacham IR.

MBio. 2014 Apr 15;5(2):e00025. doi: 10.1128/mBio.00025-14.

22.

A promoter-level mammalian expression atlas.

FANTOM Consortium and the RIKEN PMI and CLST (DGT), Forrest AR, Kawaji H, Rehli M, Baillie JK, de Hoon MJ, Haberle V, Lassmann T, Kulakovskiy IV, Lizio M, Itoh M, Andersson R, Mungall CJ, Meehan TF, Schmeier S, Bertin N, Jørgensen M, Dimont E, Arner E, Schmidl C, Schaefer U, Medvedeva YA, Plessy C, Vitezic M, Severin J, Semple C, Ishizu Y, Young RS, Francescatto M, Alam I, Albanese D, Altschuler GM, Arakawa T, Archer JA, Arner P, Babina M, Rennie S, Balwierz PJ, Beckhouse AG, Pradhan-Bhatt S, Blake JA, Blumenthal A, Bodega B, Bonetti A, Briggs J, Brombacher F, Burroughs AM, Califano A, Cannistraci CV, Carbajo D, Chen Y, Chierici M, Ciani Y, Clevers HC, Dalla E, Davis CA, Detmar M, Diehl AD, Dohi T, Drabløs F, Edge AS, Edinger M, Ekwall K, Endoh M, Enomoto H, Fagiolini M, Fairbairn L, Fang H, Farach-Carson MC, Faulkner GJ, Favorov AV, Fisher ME, Frith MC, Fujita R, Fukuda S, Furlanello C, Furino M, Furusawa J, Geijtenbeek TB, Gibson AP, Gingeras T, Goldowitz D, Gough J, Guhl S, Guler R, Gustincich S, Ha TJ, Hamaguchi M, Hara M, Harbers M, Harshbarger J, Hasegawa A, Hasegawa Y, Hashimoto T, Herlyn M, Hitchens KJ, Ho Sui SJ, Hofmann OM, Hoof I, Hori F, Huminiecki L, Iida K, Ikawa T, Jankovic BR, Jia H, Joshi A, Jurman G, Kaczkowski B, Kai C, Kaida K, Kaiho A, Kajiyama K, Kanamori-Katayama M, Kasianov AS, Kasukawa T, Katayama S, Kato S, Kawaguchi S, Kawamoto H, Kawamura YI, Kawashima T, Kempfle JS, Kenna TJ, Kere J, Khachigian LM, Kitamura T, Klinken SP, Knox AJ, Kojima M, Kojima S, Kondo N, Koseki H, Koyasu S, Krampitz S, Kubosaki A, Kwon AT, Laros JF, Lee W, Lennartsson A, Li K, Lilje B, Lipovich L, Mackay-Sim A, Manabe R, Mar JC, Marchand B, Mathelier A, Mejhert N, Meynert A, Mizuno Y, de Lima Morais DA, Morikawa H, Morimoto M, Moro K, Motakis E, Motohashi H, Mummery CL, Murata M, Nagao-Sato S, Nakachi Y, Nakahara F, Nakamura T, Nakamura Y, Nakazato K, van Nimwegen E, Ninomiya N, Nishiyori H, Noma S, Noma S, Noazaki T, Ogishima S, Ohkura N, Ohimiya H, Ohno H, Ohshima M, Okada-Hatakeyama M, Okazaki Y, Orlando V, Ovchinnikov DA, Pain A, Passier R, Patrikakis M, Persson H, Piazza S, Prendergast JG, Rackham OJ, Ramilowski JA, Rashid M, Ravasi T, Rizzu P, Roncador M, Roy S, Rye MB, Saijyo E, Sajantila A, Saka A, Sakaguchi S, Sakai M, Sato H, Savvi S, Saxena A, Schneider C, Schultes EA, Schulze-Tanzil GG, Schwegmann A, Sengstag T, Sheng G, Shimoji H, Shimoni Y, Shin JW, Simon C, Sugiyama D, Sugiyama T, Suzuki M, Suzuki N, Swoboda RK, 't Hoen PA, Tagami M, Takahashi N, Takai J, Tanaka H, Tatsukawa H, Tatum Z, Thompson M, Toyodo H, Toyoda T, Valen E, van de Wetering M, van den Berg LM, Verado R, Vijayan D, Vorontsov IE, Wasserman WW, Watanabe S, Wells CA, Winteringham LN, Wolvetang E, Wood EJ, Yamaguchi Y, Yamamoto M, Yoneda M, Yonekura Y, Yoshida S, Zabierowski SE, Zhang PG, Zhao X, Zucchelli S, Summers KM, Suzuki H, Daub CO, Kawai J, Heutink P, Hide W, Freeman TC, Lenhard B, Bajic VB, Taylor MS, Makeev VJ, Sandelin A, Hume DA, Carninci P, Hayashizaki Y.

Nature. 2014 Mar 27;507(7493):462-70. doi: 10.1038/nature13182.

23.

Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction.

Park JS, Koentjoro B, Veivers D, Mackay-Sim A, Sue CM.

Hum Mol Genet. 2014 Jun 1;23(11):2802-15. doi: 10.1093/hmg/ddt623. Epub 2014 Jan 7.

24.

Surface coatings of ZnO nanoparticles mitigate differentially a host of transcriptional, protein and signalling responses in primary human olfactory cells.

Osmond-McLeod MJ, Osmond RI, Oytam Y, McCall MJ, Feltis B, Mackay-Sim A, Wood SA, Cook AL.

Part Fibre Toxicol. 2013 Oct 21;10(1):54. doi: 10.1186/1743-8977-10-54.

25.

Clinical trials for the treatment of spinal cord injury: not so simple.

Mackay-Sim A, Féron F.

Methods Mol Biol. 2013;1059:229-37. doi: 10.1007/978-1-62703-574-3_18. Review.

PMID:
23934846
26.

Isolation of adult stem cells from the human olfactory mucosa.

Féron F, Perry C, Girard SD, Mackay-Sim A.

Methods Mol Biol. 2013;1059:107-14. doi: 10.1007/978-1-62703-574-3_10.

PMID:
23934838
27.

Loss of Usp9x disrupts cortical architecture, hippocampal development and TGFβ-mediated axonogenesis.

Stegeman S, Jolly LA, Premarathne S, Gecz J, Richards LJ, Mackay-Sim A, Wood SA.

PLoS One. 2013 Jul 5;8(7):e68287. doi: 10.1371/journal.pone.0068287. Print 2013.

28.

Patient-derived stem cells: pathways to drug discovery for brain diseases.

Mackay-Sim A.

Front Cell Neurosci. 2013 Mar 27;7:29. doi: 10.3389/fncel.2013.00029. eCollection 2013.

29.

Focal adhesion dynamics are altered in schizophrenia.

Fan Y, Abrahamsen G, Mills R, Calderón CC, Tee JY, Leyton L, Murrell W, Cooper-White J, McGrath JJ, Mackay-Sim A.

Biol Psychiatry. 2013 Sep 15;74(6):418-26. doi: 10.1016/j.biopsych.2013.01.020. Epub 2013 Mar 5.

PMID:
23482246
30.

A patient-derived olfactory stem cell disease model for ataxia-telangiectasia.

Stewart R, Kozlov S, Matigian N, Wali G, Gatei M, Sutharsan R, Bellette B, Wraith-Kijas A, Cochrane J, Coulthard M, Perry C, Sinclair K, Mackay-Sim A, Lavin MF.

Hum Mol Genet. 2013 Jun 15;22(12):2495-509. doi: 10.1093/hmg/ddt101. Epub 2013 Mar 7.

PMID:
23474819
31.

Phagocytosis of bacteria by olfactory ensheathing cells and Schwann cells.

Panni P, Ferguson IA, Beacham I, Mackay-Sim A, Ekberg JA, St John JA.

Neurosci Lett. 2013 Feb 28;539:65-70. doi: 10.1016/j.neulet.2013.01.052. Epub 2013 Feb 14.

PMID:
23415759
32.

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations.

Abrahamsen G, Fan Y, Matigian N, Wali G, Bellette B, Sutharsan R, Raju J, Wood SA, Veivers D, Sue CM, Mackay-Sim A.

Dis Model Mech. 2013 Mar;6(2):489-502. doi: 10.1242/dmm.010884. Epub 2012 Dec 20. Erratum in: Dis Model Mech. 2015 Oct 1;8(10):1339.

33.

Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice.

Groves NJ, Kesby JP, Eyles DW, McGrath JJ, Mackay-Sim A, Burne TH.

Behav Brain Res. 2013 Mar 15;241:120-31. doi: 10.1016/j.bbr.2012.12.001. Epub 2012 Dec 10.

PMID:
23238039
34.

Variability in the generation of induced pluripotent stem cells: importance for disease modeling.

Vitale AM, Matigian NA, Ravishankar S, Bellette B, Wood SA, Wolvetang EJ, Mackay-Sim A.

Stem Cells Transl Med. 2012 Sep;1(9):641-50. doi: 10.5966/sctm.2012-0043. Epub 2012 Sep 7.

35.

Leukaemia inhibitory factor stimulates proliferation of olfactory neuronal progenitors via inducible nitric oxide synthase.

Lopez-Arenas E, Mackay-Sim A, Bacigalupo J, Sulz L.

PLoS One. 2012;7(9):e45018. Epub 2012 Sep 14.

36.

Concise review: Patient-derived olfactory stem cells: new models for brain diseases.

Mackay-Sim A.

Stem Cells. 2012 Nov;30(11):2361-5. doi: 10.1002/stem.1220. Review.

37.

Olfactory discrimination predicts cognitive decline among community-dwelling older adults.

Sohrabi HR, Bates KA, Weinborn MG, Johnston AN, Bahramian A, Taddei K, Laws SM, Rodrigues M, Morici M, Howard M, Martins G, Mackay-Sim A, Gandy SE, Martins RN.

Transl Psychiatry. 2012 May 22;2:e118. doi: 10.1038/tp.2012.43.

38.

The migration of olfactory ensheathing cells during development and regeneration.

Ekberg JA, Amaya D, Mackay-Sim A, St John JA.

Neurosignals. 2012;20(3):147-58. doi: 10.1159/000330895. Epub 2012 Mar 27. Review.

39.

Altered cell cycle dynamics in schizophrenia.

Fan Y, Abrahamsen G, McGrath JJ, Mackay-Sim A.

Biol Psychiatry. 2012 Jan 15;71(2):129-35. doi: 10.1016/j.biopsych.2011.10.004. Epub 2011 Nov 9.

PMID:
22074612
40.

Two phases of replacement replenish the olfactory ensheathing cell population after injury in postnatal mice.

Chehrehasa F, Ekberg JA, Lineburg K, Amaya D, Mackay-Sim A, St John JA.

Glia. 2012 Feb;60(2):322-32. doi: 10.1002/glia.22267. Epub 2011 Nov 7.

PMID:
22065423
41.

Stem cell models for biomarker discovery in brain disease.

Mackay-Sim A, Mellick G, Wood S.

Int Rev Neurobiol. 2011;101:239-57. doi: 10.1016/B978-0-12-387718-5.00009-2. Review.

PMID:
22050854
42.

Variance of gene expression identifies altered network constraints in neurological disease.

Mar JC, Matigian NA, Mackay-Sim A, Mellick GD, Sue CM, Silburn PA, McGrath JJ, Quackenbush J, Wells CA.

PLoS Genet. 2011 Aug;7(8):e1002207. doi: 10.1371/journal.pgen.1002207. Epub 2011 Aug 11.

43.

NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease.

Cook AL, Vitale AM, Ravishankar S, Matigian N, Sutherland GT, Shan J, Sutharsan R, Perry C, Silburn PA, Mellick GD, Whitelaw ML, Wells CA, Mackay-Sim A, Wood SA.

PLoS One. 2011;6(7):e21907. doi: 10.1371/journal.pone.0021907. Epub 2011 Jul 1.

44.

Vascular endothelial growth factor and platelet derived growth factor modulates the glial response to a cortical stab injury.

Norazit A, Nguyen MN, Dickson CG, Tuxworth G, Goss B, Mackay-Sim A, Meedeniya AC.

Neuroscience. 2011 Sep 29;192:652-60. doi: 10.1016/j.neuroscience.2011.06.035. Epub 2011 Jun 24.

PMID:
21704679
45.

The carbohydrate CT1 is expressed in topographically fixed glomeruli in the mouse olfactory bulb.

Lineburg KE, Amaya D, Ekberg JA, Chehrehasa F, Mackay-Sim A, Martin PT, Key B, St John JA.

Mol Cell Neurosci. 2011 Sep;48(1):9-19. doi: 10.1016/j.mcn.2011.05.011. Epub 2011 Jun 12.

PMID:
21699983
46.

Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.

Khoo ML, Tao H, Meedeniya AC, Mackay-Sim A, Ma DD.

PLoS One. 2011;6(5):e19025. doi: 10.1371/journal.pone.0019025. Epub 2011 May 23.

47.

Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury.

Lutton C, Young YW, Williams R, Meedeniya AC, Mackay-Sim A, Goss B.

J Neurotrauma. 2012 Mar 20;29(5):957-70. doi: 10.1089/neu.2010.1423. Epub 2011 Aug 9.

PMID:
21568693
48.

Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.

Park JS, Mehta P, Cooper AA, Veivers D, Heimbach A, Stiller B, Kubisch C, Fung VS, Krainc D, Mackay-Sim A, Sue CM.

Hum Mutat. 2011 Aug;32(8):956-64. doi: 10.1002/humu.21527. Epub 2011 Jul 12.

PMID:
21542062
49.

Characterization of olfactory stem cells.

Wetzig A, Mackay-Sim A, Murrell W.

Cell Transplant. 2011;20(11-12):1673-91. doi: 10.3727/096368911X576009. Epub 2011 Apr 29.

PMID:
21535908
50.

Induced pluripotent stem cells: a new technology to study human diseases.

Vitale AM, Wolvetang E, Mackay-Sim A.

Int J Biochem Cell Biol. 2011 Jun;43(6):843-6. doi: 10.1016/j.biocel.2011.03.013. Epub 2011 Mar 31. Review.

PMID:
21458591

Supplemental Content

Loading ...
Support Center